New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) ...
Researchers at IIT Kanpur, led by Professor Arun K Shukla, have uncovered the molecular basis underlying the atypical signalling behaviour of C5aR2, an immune receptor that has puzzled scientists for ...
IIT Kanpur researchers solve mystery of atypical drug target receptor ...
Scientists at IIT Kanpur have uncovered how a little-understood immune system receptor works, solving a question that has ...
Atherosclerosis is a lipid-driven chronic inflammatory disease that is modulated by innate and adaptive immunity including humoral immunity. Importantly, antibody alterations achieved by genetic means ...
Managing complement 3 glomerulopathy involves several treatment options aimed at slowing disease progression and protecting kidney function. These may include blood pressure control, steroids, ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results